Laryngeal neuroendocrine carcinoma is a rare tumour of the larynx, accounting for only about 1% of all primary laryngeal tumours. Laryngeal neuroendocrine carcinomas are classified as well-, moderate-and poorly-differentiated neuroendocrine carcinoma. The differentiating features of each category include nuclear atypia, mitotic rate and presence or absence of necrosis. Immunochemistry stains also help in diagnosing laryngeal neuroendocrine carcinoma. In this article, we present a case report of moderately-differentiated neuroendocrine carcinoma of the larynx in a 57-year-old man who presented with neck pain and dysphagia persisting for one month. There is no standard treatment regimen for laryngeal neuroendocrine carcinoma. However, due to the poor prognosis for moderately-differentiated laryngeal neuroendocrine carcinomas, we advocate aggressive and prompt treatment and surveillance PET-CT scan 6 months postoperatively.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.